214 related articles for article (PubMed ID: 8925853)
1. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
2. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation.
Sykes TR; Woo TK; Baum RP; Qi P; Noujaim AA
J Nucl Med; 1995 Oct; 36(10):1913-22. PubMed ID: 7562064
[TBL] [Abstract][Full Text] [Related]
3. [Use of photoactivation in the preparation of radiopharmaceuticals. III. Human serum albumin labelled with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 1997 Oct; 46(5):217-21. PubMed ID: 9600144
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
Zhang ZM; Ballinger JR; Sheldon K; Boxen I
Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.
Gooden CS; Snook DE; Epenetos AA
Cell Biophys; 1993; 22(1-3):49-59. PubMed ID: 7889542
[TBL] [Abstract][Full Text] [Related]
6. Site-specific conjugation and labelling of prostate antibody 7E11C5.3 (CYT-351) with technetium-99m.
Stalteri MA; Mather SJ; Belinka BA; Coughlin DJ; Chengazi VU; Britton KE
Eur J Nucl Med; 1997 Jun; 24(6):651-4. PubMed ID: 9169572
[TBL] [Abstract][Full Text] [Related]
7. Development of 99mTc-neomannosyl human serum albumin (99mTc-MSA) as a novel receptor binding agent for sentinel lymph node imaging.
Jeong JM; Hong MK; Kim YJ; Lee J; Kang JH; Lee DS; Chung JK; Lee MC
Nucl Med Commun; 2004 Dec; 25(12):1211-7. PubMed ID: 15640781
[TBL] [Abstract][Full Text] [Related]
8. Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodies.
Pimm MV; Rajput RS; Frier M; Gribben SJ
Eur J Nucl Med; 1991; 18(12):973-6. PubMed ID: 1778209
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; Patrício L
Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
[TBL] [Abstract][Full Text] [Related]
10. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
Pietersz GA; Patrick MR; Chester KA
J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
[TBL] [Abstract][Full Text] [Related]
11. Effect of interleukin-2 on the biodistribution of technetium-99m-labelled anti-CEA monoclonal antibody in mice bearing human tumour xenografts.
Nakamura K; Kubo A
Eur J Nucl Med; 1994 Sep; 21(9):924-9. PubMed ID: 7995285
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
13. [Use of photoactivation in the preparation of radiopharmaceuticals. II. Dialysate of human leukocytes labelled with technetium (99mTc)].
Kleisner I; Komárek P; Konopková M; Komárková I
Ceska Slov Farm; 1997 Aug; 46(4):169-73. PubMed ID: 9377062
[TBL] [Abstract][Full Text] [Related]
14. [Use of photoactivation in the preparation of radiopharmaceuticals. I. Human immunoglobulin labelled with technetium (99mTc)].
Komárek P; Kleisner I; Konopková M; Komárko I
Ceska Slov Farm; 1997 Jun; 46(3):122-7. PubMed ID: 9440949
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoscintigraphy using technetium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor.
Karube Y; Katsuno K; Takata J; Matsunaga K; Haruno M; Kuroki M; Arakawa F; Matsuoka Y; Kanda H
Nucl Med Biol; 1996 Aug; 23(6):753-9. PubMed ID: 8940717
[TBL] [Abstract][Full Text] [Related]
16. Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human.
Oriuchi N; Watanabe N; Sugiyama S; Higuchi T; Imai K; Yamanaka H; Hashimoto M; Kanda H; Endo K
Br J Cancer; 1996 Jun; 73(12):1466-72. PubMed ID: 8664114
[TBL] [Abstract][Full Text] [Related]
17. Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: a comparison of radiochemical behavior and biological efficacy with other labelling methods.
Gano L; Patrício L; Marques E; Cantinho G; Pena H; Martins T; Hnatowich DJ
Nucl Med Biol; 1998 May; 25(4):395-403. PubMed ID: 9639302
[TBL] [Abstract][Full Text] [Related]
18. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
19. The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
Mardirossian G; Wu C; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 1992 Jul; 13(7):503-12. PubMed ID: 1495677
[TBL] [Abstract][Full Text] [Related]
20. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
